This study tests whether a daily 10 mg pill called Xanamem can safely slow memory and function loss in people with mild or moderate Alzheimer's dementia. About 247 participants will receive either Xanamem or a placebo for 36 weeks, with an option to continue the drug for up to 10…
Phase: PHASE2, PHASE3 • Sponsor: Actinogen Medical • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC